Lab
Ponce Medical School Foundation, INC.
Ponce Medical School Foundation, INC. was paid $885K by Medicaid between Jan 2018 and Dec 2024, across 25 billing codes. Its largest line is 87536, — 45% of everything it billed.
33Billing provider infoPONCE MEDICAL SCHOOL FOUNDATION, INC.
PONCE, PR 00732
PONCE, PR 00732
33aNPI1265644868assigned 05/04/2007
33bProvider typeClinical Medical Laboratory
28Total paid$885K
24GClaims24,631
24DCodes billed25
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#142 of 777
Median peer was paid$278K
This provider vs. median3.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,899 | $84K | |
| 2019 | 2,366 | $90K | |
| 2020 | 4,341 | $149K | |
| 2021 | 4,023 | $128K | |
| 2022 | 4,340 | $143K | |
| 2023 | 3,453 | $137K | |
| 2024incomplete | 4,209 | $154K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87536 | 45% | 5,464 | 5,029 | $399K | |
| 86360 | 25% | 5,427 | 4,993 | $218K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 11% | 2,210 | 2,051 | $99K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5.6% | 2,345 | 2,194 | $49K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.1% | 5,690 | 5,206 | $37K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.9% | 807 | 768 | $35K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.4% | 533 | 490 | $21K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 218 | 215 | $12K |
| 36415 | Collection of venous blood by venipuncture | <1% | 590 | 543 | $4K |
| 80061 | Lipid panel | <1% | 250 | 189 | $2K |
| 87522 | Neg quan hep c or qual rna | <1% | 56 | 48 | $2K |
| 80053 | Comprehensive metabolic panel | <1% | 242 | 197 | $2K |
13 more codes
| 85027 | <1% | 186 | $1K | |
| 81000 | <1% | 320 | $700.09 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 41 | $548.69 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 71 | $512.53 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 16 | $470.79 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 16 | $470.79 |
| 86769 | <1% | 17 | $370.14 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 25 | $230.40 |
| 86738 | <1% | 13 | $105.36 | |
| 82043 | <1% | 44 | $105.13 | |
| 82570 | <1% | 16 | $67.96 | |
| 86592 | <1% | 17 | $55.31 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 17 | $41.53 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMPSON, KENIRA (PRESIDENT)